GRNT NIDA-CENIC-P1S1 Investigating the Impact of Nicotine Using Spectrum Cigarettes (P1S1) - Grant U54-DA031659
Eric C. Donny, Ph.D. Feb 14, 2020
DTMC NIDA-CSP-1022 Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation
Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH May 07, 2018
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study
Robert P Schwartz, M.D. , Li-Tzy Wu, ScD. , Jennifer McNeely, M.D. Sep 14, 2017
CTN NIDA-CTN-0046 Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Nov 19, 2013
CTN NIDA-CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Dec 15, 2009
CTN NIDA-CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs
Malcolm Reid, Ph.D. Dec 03, 2007
